Gender differences in referrals for deep brain stimulation for essential tremor.

Deep brain stimulation (DBS) is an established treatment for essential tremor (ET). Gender differences in DBS have been recognized for Parkinson's disease. In this systematic chart review, we also observed a gender differences in DBS for ET. The main reason was an underrepresentation of women in referrals for surgical evaluation.
Competing Interests: Declaration of competing interest P.R. none. S.T.J. was funded by the Prof. Klaus Thiemann Foundation. P.S. none; A.G. none. G.R.F. was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—Project-ID 431549029—SFB 1451. G.R.F. serves as an editorial board member of Cortex, Neurological Research and Practice, NeuroImage: Clinical, Zeitschrift für Neuropsychologie, and DGNeurologie; receives royalties from the publication of the books Funktionelle MRT in Psychiatrie und Neurologie, Neurologische Differentialdiagnose, and SOP Neurologie; receives royalties from the publication of the neuropsychological tests KAS and Köpps; received honoraria for speaking engagements from Bayer, Desitin, DGN, Ergo DKV, Forum für medizinische Fortbildung FomF GmbH, GSK, Medica Academy Messe Düsseldorf, Medicbrain Healthcare, Novartis, Pfizer, and Sportärztebund NRW. V·V.V. has received honoraria for active participation in congresses and advisory boards from Medtronic, Boston Scientific and Functional Neuromodulation. K.A. has received honoraria for educational meetings, travel and consultancy from Medtronic, St. Jude Medical and Boston Scientific. A.R. has received honorarium from UCB and was supported by a grant from Medtronic. P.M-M. has received honoraria from the International Parkinson and Movement Disorder Society (MDS) for management of the Clinical Outcome Assessment Program. L.S. none. Af.S. none. L.T. reports grants, personal fees and non-financial support from SAPIENS Steering Brain Stimulation, Medtronic, Boston Scientific and St. Jude Medical. An. S. is funded by the Gusyk program and the Advanced Cologne Clinician Scientist program of the Medical Faculty of the University of Cologne and has received funding from the Prof. Klaus Thiemann Foundation. K.R.C. has received funding from Parkinson's UK, NIHR, UCB, and the European Union; he received honoraria from UCB, Abbott, Britannia, US Worldmeds, and Otsuka Pharmaceuticals; and acted as a consultant for AbbVie, UCB, and Britannia. E.K. has received grants from the German Ministry of Education and Research, the German Parkinson- Fonds, the German Parkinson Society; honoraria from: Oticon GmbH, Hamburg, Germany; Lilly Pharma GmbH, Bad Homburg, Germany; Bernafon AG, Bern, Switzerland; Desitin GmbH, Hamburg, Germany. H·S.D. reports funding of his work by the EU Joint Programme - Neurodegenerative Disease Research (JPND), the Prof. Klaus Thiemann Foundation, the Felgenhauer Foundation, and the Koeln Fortune Program, and honoraria by Boston Scientific, Medtronic and Stadapharm.
(Copyright © 2023 Elsevier Ltd. All rights reserved.)